SCOPE 2018

PCI to acquire Australia-based clinical trial services company

By Melissa Fassbender contact

- Last updated on GMT

(Image: PCI Pharma Services)
(Image: PCI Pharma Services)

Related tags: Pci pharma services, Pharmacology, Clinical trial

PCI Pharma Services (PCI) has announced its intent to acquire Pharmaceutical Packaging Professionals (PPP) as the company focuses on growth and rapid expansion.

The acquisition – PCI’s fifth outside the US in five years – enables it to better support customers from early phases of clinical development to commercial launch, according to the pharmaceutical outsourcing services provider

Melbourne, Australia-based PPP has a focus on early phase development, with services including early clinical phase sterile and non-sterile drug manufacture, packaging and labeling, in addition to logistical services such storage and distribution.

There’s a lot of Phase I activity in Australia​,” Justin Schroeder, senior executive director, Global Marketing and Design, PCI, told us at the SCOPE Summit this week in Orland, FL, adding that PPP’s services are complementary to PCI's portfolio of clinical and commercial services.

Additionally, access to the Asia Pacific region expands PCI’s footprint in that area, which is a growing part of the clinical trial community for regional investigational site activity, he added.

PCI plans to fully integrate PPP under the PCI pharma Services brand, Schroeder explained. “We anticipate we’ll retain all of the positions​,” he said.

Schroeder added the company is “really focused on growth​” and expects “rapid expansion​.”

Currently, PPP is expanding one of its facilities to up its storage and distribution services and add labeling and packaging rooms, Grade D manufacturing, and sterile-fill manufacturing capabilities for Phase II clinical studies.

In October of 2017, PCI acquired the pharmaceutical and healthcare contract packaging services provider Millmount Healthcare based in Dublin, Ireland. The company has also been investing in site expansions at its US and UK-based locations.

Related news

Show more

Related products

show more

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Introduction to eLAS®

Introduction to eLAS®

Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

Related suppliers

Follow us

Products

View more

Webinars